1-5 of 5
Authors: Jeff Alder
Journal Article
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials Free
Clinical Infectious Diseases, Volume 69, Issue 11, 1 December 2019, Pages 1912–1918, https://doi.org/10.1093/cid/ciz093
Published: 04 February 2019
Journal Article
New Antimicrobial Agents … but No Susceptibility Tests! Free
Clinical Infectious Diseases, Volume 63, Issue 11, 1 December 2016, Pages 1530–1531, https://doi.org/10.1093/cid/ciw603
Published: 31 August 2016
Journal Article
Developing Outcomes Assessments as Endpoints for Registrational Clinical Trials of Antibacterial Drugs: 2015 Update From the Biomarkers Consortium of the Foundation for the National Institutes of Health Free
Clinical Infectious Diseases, Volume 62, Issue 5, 1 March 2016, Pages 603–607, https://doi.org/10.1093/cid/civ927
Published: 13 December 2015
Journal Article
Effects of Prior Effective Therapy on the Efficacy of Daptomycin and Ceftriaxone for the Treatment of Community-Acquired Pneumonia Get access
Clinical Infectious Diseases, Volume 46, Issue 8, 15 April 2008, Pages 1142–1151, https://doi.org/10.1086/533441
Published: 15 April 2008
Journal Article
The Clinical Relevance and Correct Designation of Isolates Nonsusceptible to Daptomycin Get access
Clinical Infectious Diseases, Volume 41, Issue 3, 1 August 2005, Pages 411–412, https://doi.org/10.1086/431765
Published: 01 August 2005
